» Articles » PMID: 23399714

Abnormal Aldosterone Physiology and Cardiometabolic Risk Factors

Overview
Journal Hypertension
Date 2013 Feb 13
PMID 23399714
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormal aldosterone physiology has been implicated in the pathogenesis of cardiometabolic diseases. Single aldosterone measurements capture only a limited range of aldosterone physiology. New methods of characterizing aldosterone physiology may provide a more comprehensive understanding of its relationship with cardiometabolic disease. We evaluated whether novel indices of aldosterone responses to dietary sodium modulation, the sodium-modulated aldosterone suppression-stimulation index (SASSI for serum and SAUSSI for urine), could predict cardiometabolic risk factors. We performed cross-sectional analyses on 539 subjects studied on liberal and restricted sodium diets with serum and urinary aldosterone measurements. SASSI and SAUSSI were calculated as the ratio of aldosterone on liberal (maximally suppressed aldosterone) to the aldosterone on restricted (stimulated aldosterone) diets and associated with risk factors using adjusted regression models. Cardiometabolic risk factors associated with either impaired suppression of aldosterone on liberal diet, or impaired stimulation on restricted diet, or both; in all of these individual cases, these risk factors associated with higher SASSI or SAUSSI. In the context of abnormalities that constitute the metabolic syndrome, there was a strong positive association between the number of metabolic syndrome components (0-4) and both SASSI and SAUSSI (P<0.0001) that was independent of known aldosterone secretagogues (angiotensin II, corticotropin, potassium). SASSI and SAUSSI exhibited a high sensitivity in detecting normal individuals with zero metabolic syndrome components (86% for SASSI and 83% for SAUSSI). Assessing the physiological range of aldosterone responses may provide greater insights into adrenal pathophysiology. Dysregulated aldosterone physiology may contribute to, or result from, early cardiometabolic abnormalities.

Citing Articles

Characterizing the Origins of Primary Aldosteronism.

Brown J, Honzel B, Tsai L, Milks J, Neibuhr Y, Neibuhr Y Hypertension. 2024; 82(2):306-318.

PMID: 39660429 PMC: 11735322. DOI: 10.1161/HYPERTENSIONAHA.124.24153.


The Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study.

Parksook W, Brown J, Omata K, Tezuka Y, Ono Y, Satoh F J Clin Endocrinol Metab. 2024; 109(9):2220-2232.

PMID: 38450549 PMC: 11319004. DOI: 10.1210/clinem/dgae145.


Elevated Blood Pressure and Aldosterone Dysregulation in Young Black Women Versus White Women on Controlled Sodium Diets.

Yuan Y, Haas A, Rosner B, Adler G, Williams G J Clin Endocrinol Metab. 2023; 109(2):e773-e779.

PMID: 37650607 PMC: 10795929. DOI: 10.1210/clinem/dgad512.


Waist-to-Height Ratio Is a Stronger Mediator in the Association between DASH Diet and Hypertension: Potential Micro/Macro Nutrients Intake Pathways.

Yuan M, Li Q, Yang C, Zhi L, Zhuang W, Xu X Nutrients. 2023; 15(9).

PMID: 37432361 PMC: 10180957. DOI: 10.3390/nu15092189.


Association Between Life's Simple 7 and Biomarkers of Cardiovascular Disease: Aldosterone, Interleukin-6, C-Reactive Protein.

Yuan Y, Haas A, Williams G, Taylor H, Seely E, Adler G J Am Heart Assoc. 2023; 12(10):e028718.

PMID: 37158153 PMC: 10227293. DOI: 10.1161/JAHA.122.028718.


References
1.
Vaidya A, Sun B, Larson C, Forman J, Williams J . Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. J Clin Endocrinol Metab. 2012; 97(7):2456-65. PMC: 3387405. DOI: 10.1210/jc.2012-1156. View

2.
Dluhy R, AXELROD L, UNDERWOOD R, Williams G . Studies of the control of plasma aldosterone concentration in normal man. II. Effect of dietary potassium and acute potassium infusion. J Clin Invest. 1972; 51(8):1950-7. PMC: 292351. DOI: 10.1172/JCI107001. View

3.
Briones A, Nguyen Dinh Cat A, Callera G, Yogi A, Burger D, He Y . Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension. 2012; 59(5):1069-78. DOI: 10.1161/HYPERTENSIONAHA.111.190223. View

4.
Schmidt M, Duncan B, Watson R, Sharrett A, Brancati F, Heiss G . A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care. 1996; 19(5):414-8. DOI: 10.2337/diacare.19.5.414. View

5.
Shoback D, Williams G, Hollenberg N, Davies R, Moore T, Dluhy R . Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man. J Clin Endocrinol Metab. 1983; 57(4):764-70. DOI: 10.1210/jcem-57-4-764. View